Skip to content

Incidence of postoperative nausea and vomiting after remimazolam or propofol anesthesia

Incidence of postoperative nausea and vomiting after remimazolam or propofol based total intravenous anesthesia for breast surgery: A randomized controlled non-inferiority trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008825
Enrollment
84
Registered
2023-09-25
Start date
2023-08-30
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : In both groups, target controlled infusion of Remifentanil was started at a plasma target concentration of 4 ng/ml. a. Propofol group: To induce anesthesia, intravenous infusion of propofol is

Sponsors

Yonsei University Health System, Severance Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Non-smoking adult female patients aged 19 years or older undergoing elective partial mastectomy under general anesthesia at Yonsei Cancer Center

Exclusion criteria

Exclusion criteria: 1. Patients with a history of hypersensitivity or allergy to propofol or remimazolam 2. Patients who are contraindicated for propofol total intravenous anesthesia 3. Patients who are contraindicated for Remimazolam anesthesia 4. Pregnant women, patients with ASA PS-III abnormality

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative nausea within 24 hours after completion of surgery

Secondary

MeasureTime frame
Incidence of postoperative vomiting within 24 hours after completion of surgery;Severity of postoperative nausea within 24 hours after completion of surgery;Dose of rescue analgesics administered up to 24 hours after surgery;Dose of rescue antiemetics administered up to 24 hours after surgery;Pain score in the recovery room immediately after surgery;Satisfaction with pain control after postoperative 24 hours;Incidence of intraoperative hypotention

Countries

Korea, Republic of

Contacts

Public ContactYoungwon Kim

Yonsei University Health System, Severance Hospital

youngwon.md@gmail.com+82-2-2224-1465

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026